Impact of Glucose-Lowering Agents on the Risk of Cancer in Type 2 Diabetic Patients. The Barcelona Case-Control Study

Por Simó, Rafael, Plana-Ripoll, Oleguer, Puente, Diana, Morros, Rosa, Mundet, Xavier, Vilca, Luz M., Hernández, Cristina, Fuentes, Inmaculada, Procupet, Adriana, Tabernero, Josep M., Violán, Concepción
Publicado em 2013